PCM
NVRO

Portolan Capital Management’s NEVRO CORP. NVRO Stock Holding History

Portolan Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-31,605
Closed -$1.8M – 103
2018
Q3 		$1.8M Sell
31,605
-1,501
-5% -$93.8K 0.18% 82
2018
Q2 		$2.64M Sell
33,106
-3
-0% -$249 0.27% 79
2018
Q1 		$2.87M Sell
33,109
-226
-0.7% -$18.2K 0.31% 81
2017
Q4 		$2.3M Sell
33,335
-22,682
-40% -$1.81M 0.25% 96
2017
Q3 		$5.09M Buy
+56,017
New +$4.8M 0.61% 63

Other funds holding NVRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Portolan Capital Management's NVRO Position: Q4 2018 in Review

Portolan Capital Management sold out of NEVRO CORP. (NVRO) in Q4 2018, closing a stake of 31,605 shares — an estimated $1.8M sold.

Portolan Capital Management first reported a position in NVRO in Q3 2017 and held it in 5 quarters. The position peaked at $5.09M in Q3 2017. 157 funds tracked by Wall St. Rank hold NVRO as of Q4 2018.

  • Portolan Capital Management reported no remaining NEVRO CORP. position as of Q4 2018 after selling out during the quarter.
  • Portolan Capital Management sold 31,605 NEVRO CORP. shares in Q4 2018, an estimated $1.8M.
  • Portolan Capital Management first reported a position in NEVRO CORP. in Q3 2017 and held it in 5 quarters.
  • Portolan Capital Management's NEVRO CORP. position peaked at $5.09M in Q3 2017.
  • 157 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2018.

Based on Portolan Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.